Invention Grant
- Patent Title: Anti-podocalyxin antibodies and methods of using the same
-
Application No.: US17402460Application Date: 2021-08-13
-
Publication No.: US12053524B2Publication Date: 2024-08-06
- Inventor: Kelley Marshall McNagny , Calvin D. Roskelley , Michael R. Hughes , Diana Canals Hernaez , Klas Ola Blixt , John Stephen Babcook , Christopher John Bond , Ismael Samudio , Jan Peter Bergqvist , Katherine Grace MacDonald , Anna Von Rossum , Bradley John Hedberg , Pamela Megan Dean
- Applicant: CENTRE FOR DRUG RESEARCH AND DEVELOPMENT , THE UNIVERSITY OF BRITISH COLUMBIA
- Applicant Address: CA Vancouver
- Assignee: CENTRE FOR DRUG RESEARCH AND DEVELOPMENT,THE UNIVERSITY OF BRITISH COLUMBIA
- Current Assignee: CENTRE FOR DRUG RESEARCH AND DEVELOPMENT,THE UNIVERSITY OF BRITISH COLUMBIA
- Current Assignee Address: CA Vancouver
- Agent Todd Lorenz
- The original application number of the division: US15765233
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K35/17 ; A61K39/395 ; A61K47/68 ; A61P35/00 ; C07K14/705 ; C07K14/725 ; C07K16/28 ; C07K16/30 ; C12N5/10
Abstract:
The present invention is directed to anti-podocalyxin antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of cancer.
Public/Granted literature
- US20220288203A1 ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME Public/Granted day:2022-09-15
Information query
